Efficacy of assigning treatment for participants with Chronic Myelomonocytic Leukaemia based on their individual molecular results (lenzilumab plus azacitidine versus sodium ascorbate plus azacitidine). PREACH-M: PREcision Approach to CHronic Myelomonocytic Leukaemia.
收藏Research Data Australia2025-12-20 收录
数据链接：
官方服务：
资源简介：
HeSANDA 1.0.0
